Non Toxic Multinodular Goiter

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Non Toxic Multinodular Goiter trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (3 shown)

CompletedNot Applicable

NCT04009863

HIFU Ablation vs Fixed-dose RAI-131 Therapy in Moderate-sized Non-toxic MNG

After obtaining informed consent, eligible subjects will be assigned randomly into either High intensity focused ultrasound group (HIFU) or Radioactive iodine (…

Hong Kong156 participantsStarted 2020-04-01

Treatment: Echopulse, Radioactive iodine (Radioidine i131)

UnknownPhase 4

NCT04412694

The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients.

Glucocorticoids are well known for their analgesic, anti-inflammatory, immunomodulatory and anti-emetic effects. Recovery time after thyroid surgery may depend…

Poland100 participantsStarted 2020-07-01

Treatment: Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland)., Placebo oral sweetener (Clio tablets, sweetener with a dispenser, Instantina GES, Vienna, Austria).

CompletedNot Applicable

NCT00946894

Outcomes of Different Thyroid Resections for Multinodular Non-toxic Goiter

The aim of this three-arm randomized study was to evaluate results of different thyroid resection modes among patients with bilateral multinodular non-toxic goi…

Poland600 participantsStarted 2000-01

Treatment: Total thyroidectomy, Dunhill operation